Literature DB >> 19335105

Effect of subcutaneous administration of a killed Mycobacterium avium subsp paratuberculosis vaccine on colonization of tissues following oral exposure to the organism in calves.

Raymond W Sweeney1, Robert H Whitlock, Terry L Bowersock, Diane L Cleary, Todd R Meinert, Perry L Habecker, Greg W Pruitt.   

Abstract

OBJECTIVE-To evaluate the effect of vaccination of calves with a killed Mycobacterium avium subsp paratuberculosis (MAP) vaccine on colonization of tissues following oral MAP exposure. ANIMALS-12 healthy Holstein calves. PROCEDURES-At 14 days after birth, calves received the MAP vaccine (1.0 mL, SC) or saline (0.9% NaCl) solution (1.0 mL, SC [control treatment]). Each calf received 1.2 x 10(9) CFUs of live MAP orally 21 and 22 days after vaccination. Prior to vaccination and at subsequent intervals, a blood sample was collected for ELISA detection of antibodies against MAP and for whole blood, antigen-specific, interferon (IFN)-gamma-release assay. Nine weeks after MAP challenge, calves were euthanized and various tissue samples were collected for mycobacterial culture. Interferon-gamma production in prescapular lymph node cells was measured following in vitro stimulation with MAP antigens. RESULTS-Calves were seronegative for anti-MAP antibodies at all times. Compared with the findings in control calves, antigen-specific IFN-gamma production in circulating lymphocytes and prescapular lymph node cells from vaccinated calves was significantly higher. Culture of tissues from vaccinated calves yielded significantly fewer CFUs of MAP (2,417 CFUs/g), compared with tissues from control calves (15,709 CFUs/g). Furthermore, significantly fewer tissue samples from vaccinated calves yielded MAP in culture (21.8 tissues/calf), compared with findings in control calves (27.6 tissues/calf). CONCLUSIONS AND CLINICAL RELEVANCE-Inoculation of calves with a killed MAP vaccine was associated with reduced colonization of intestinal tissues following experimental exposure to MAP. Use of the vaccine could potentially reduce transmission of MAP to calves in infected herds.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19335105     DOI: 10.2460/ajvr.70.4.493

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  13 in total

1.  A single dose polyanhydride-based nanovaccine against paratuberculosis infection.

Authors:  Akanksha Thukral; Kathleen Ross; Chungyi Hansen; Yashdeep Phanse; Balaji Narasimhan; Howard Steinberg; Adel M Talaat
Journal:  NPJ Vaccines       Date:  2020-02-14       Impact factor: 7.344

2.  Mediation of host immune responses after immunization of neonatal calves with a heat-killed Mycobacterium avium subsp. paratuberculosis vaccine.

Authors:  J R Stabel; W R Waters; J P Bannantine; K Lyashchenko
Journal:  Clin Vaccine Immunol       Date:  2011-10-26

3.  Immunogenicity and reactivity of novel Mycobacterium avium subsp. paratuberculosis PPE MAP1152 and conserved MAP1156 proteins with sera from experimentally and naturally infected animals.

Authors:  John P Bannantine; Avery L Paulson; Ofelia Chacon; Robert J Fenton; Denise K Zinniel; David S McVey; David R Smith; Charles J Czuprynski; Raúl G Barletta
Journal:  Clin Vaccine Immunol       Date:  2010-11-17

4.  Development and evaluation of a novel multicopy-element-targeting triplex PCR for detection of Mycobacterium avium subsp. paratuberculosis in feces.

Authors:  Iker A Sevilla; Joseba M Garrido; Elena Molina; María V Geijo; Natalia Elguezabal; Patricia Vázquez; Ramón A Juste
Journal:  Appl Environ Microbiol       Date:  2014-04-11       Impact factor: 4.792

5.  Early response of monocyte-derived macrophages from vaccinated and non-vaccinated goats against in vitro infection with Mycobacterium avium subsp. paratuberculosis.

Authors:  Noive Arteche-Villasol; Daniel Gutiérrez-Expósito; Raquel Vallejo; Jose Espinosa; Natalia Elguezabal; Iraia Ladero-Auñon; Marcos Royo; María Del Carmen Ferreras; Julio Benavides; Valentín Pérez
Journal:  Vet Res       Date:  2021-05-12       Impact factor: 3.683

6.  Paratuberculosis control: a review with a focus on vaccination.

Authors:  Felix Bastida; Ramon A Juste
Journal:  J Immune Based Ther Vaccines       Date:  2011-10-31

7.  Paratuberculosis vaccination causes only limited cross-reactivity in the skin test for diagnosis of bovine tuberculosis.

Authors:  Joseba M Garrido; Patricia Vazquez; Elena Molina; Jose M Plazaola; Iker A Sevilla; Maria V Geijo; Marta Alonso-Hearn; Ramon A Juste
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

8.  A murine oral model for Mycobacterium avium subsp. paratuberculosis infection and immunomodulation with Lactobacillus casei ATCC 334.

Authors:  Meagan A Cooney; James L Steele; Howard Steinberg; Adel M Talaat
Journal:  Front Cell Infect Microbiol       Date:  2014-02-05       Impact factor: 5.293

9.  Evaluation of eight live attenuated vaccine candidates for protection against challenge with virulent Mycobacterium avium subspecies paratuberculosis in mice.

Authors:  John P Bannantine; Jamie L Everman; Sasha J Rose; Lmar Babrak; Robab Katani; Raúl G Barletta; Adel M Talaat; Yrjö T Gröhn; Yung-Fu Chang; Vivek Kapur; Luiz E Bermudez
Journal:  Front Cell Infect Microbiol       Date:  2014-07-01       Impact factor: 5.293

10.  Immunity, safety and protection of an Adenovirus 5 prime--Modified Vaccinia virus Ankara boost subunit vaccine against Mycobacterium avium subspecies paratuberculosis infection in calves.

Authors:  Tim J Bull; Christina Vrettou; Richard Linedale; Catherine McGuinnes; Sam Strain; Jim McNair; Sarah C Gilbert; Jayne C Hope
Journal:  Vet Res       Date:  2014-10-29       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.